Research Articles

In-depth guides, research summaries, and educational content for the scientific community.

Tesamorelin Safety Profile and Regulatory Status: What the Trials Recorded

Tesamorelin Safety Profile and Regulatory Status: What the Trials Recorded

A systematic review of what Phase 3 clinical trials actually measured about tesamorelin's safety — organized by organ system, attributed to specific studies, and framed without conjecture. Includes a direct answer to the FDA approval question and a factual account of the GH/IGF-1 and cancer biology question.

Aug 10, 2026 · 13 min read
["Tesamorelin" "GHRH analogs" "Regulatory status"
Tesamorelin vs Sermorelin: GHRH Analogs Compared in the Research Record

Tesamorelin vs Sermorelin: GHRH Analogs Compared in the Research Record

Tesamorelin and sermorelin are both synthetic GHRH analogs acting on the same pituitary receptor, yet they differ fundamentally in molecular stability, plasma half-life, and the volume of clinical evidence behind them. This analysis maps those differences across the published research record.

Aug 10, 2026 · 14 min read
["tesamorelin" "sermorelin" "GHRH analogs"
Comparison of GLP-1 receptor agonist peptides semaglutide tirzepatide and retatrutide

Retatrutide vs Tirzepatide: Triple Agonist Compared to Dual Agonist

A detailed comparison of three incretin-based research peptides — mono-agonist semaglutide, dual-agonist tirzepatide, and triple-agonist retatrutide — covering receptor pharmacology, structural modifications, binding kinetics, metabolic pathway engagement, and practical considerations for laboratory research.

Aug 10, 2026 · 14 min read
GLP-1 Metabolic Research Semaglutide
Retatrutide Dosage in Clinical Trials: Regimens Reported in the Literature

Retatrutide Dosage in Clinical Trials: Regimens Reported in the Literature

A review of the dose escalation regimens, maintenance arms, and titration rationale documented in published phase 1 and phase 2 clinical trials of retatrutide — an investigational triple incretin receptor agonist with no regulatory approval in any jurisdiction.

Aug 10, 2026 · 12 min read
["Retatrutide" "Clinical Trials" "Dose Escalation"
Retatrutide Side Effects: Adverse Events Reported in Published Trials

Retatrutide Side Effects: Adverse Events Reported in Published Trials

A systematic review of adverse events documented in published clinical trials of retatrutide, a triple agonist investigational compound, including gastrointestinal event rates, discontinuation data, and the mechanistic reasons its safety profile diverges from dual-agonist predecessors.

Aug 10, 2026 · 14 min read
["Retatrutide" "Incretin Pharmacology" "Triple Agonist"
Epithalon (Ala-Glu-Asp-Gly): Telomerase Research and What Replicated

Epithalon (Ala-Glu-Asp-Gly): Telomerase Research and What Replicated

Epithalon is the one Khavinson bioregulator with current international replication. A citation-by-citation summary of the telomerase work, from the 2003 original through independent 2025 studies — including the correction notice.

Aug 6, 2026 · 11 min read
epithalon epitalon bioregulator